TY  - GEN
AU  - Röllig,Christoph
AU  - Serve,Hubert
AU  - Hüttmann,Andreas
AU  - Noppeney,Richard
AU  - Müller-Tidow,Carsten
AU  - Krug,Utz
AU  - Baldus,Claudia D
AU  - Brandts,Christian H
AU  - Kunzmann,Volker
AU  - Einsele,Hermann
AU  - Krämer,Alwin
AU  - Schäfer-Eckart,Kerstin
AU  - Neubauer,Andreas
AU  - Burchert,Andreas
AU  - Giagounidis,Aristoteles
AU  - Krause,Stefan W
AU  - Mackensen,Andreas
AU  - Aulitzky,Walter
AU  - Herbst,Regina
AU  - Hänel,Mathias
AU  - Kiani,Alexander
AU  - Frickhofen,Norbert
AU  - Kullmer,Johannes
AU  - Kaiser,Ulrich
AU  - Link,Hartmut
AU  - Geer,Thomas
AU  - Reichle,Albert
AU  - Junghanß,Christian
AU  - Repp,Roland
AU  - Heits,Frank
AU  - Dürk,Heinz
AU  - Hase,Jana
AU  - Klut,Ina-Maria
AU  - Illmer,Thomas
AU  - Bornhäuser,Martin
AU  - Schaich,Markus
AU  - Parmentier,Stefani
AU  - Görner,Martin
AU  - Thiede,Christian
AU  - von Bonin,Malte
AU  - Schetelig,Johannes
AU  - Kramer,Michael
AU  - Berdel,Wolfgang E
AU  - Ehninger,Gerhard
TI  - Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
SN  - 1474-5488
PY  - 2016///0418
KW  - Adult
KW  - Age Factors
KW  - Antibiotics, Antineoplastic
KW  - therapeutic use
KW  - Antimetabolites, Antineoplastic
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Chemotherapy, Adjuvant
KW  - Cytarabine
KW  - Daunorubicin
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Double-Blind Method
KW  - Female
KW  - Germany
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Leukemia, Myeloid, Acute
KW  - diagnosis
KW  - Male
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Niacinamide
KW  - Phenylurea Compounds
KW  - Proportional Hazards Models
KW  - Protein Kinase Inhibitors
KW  - Recurrence
KW  - Risk Factors
KW  - Sorafenib
KW  - Time Factors
KW  - Transplantation, Homologous
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S1470-2045(15)00362-9
ER  -